Evidence map›Paper›PMID 41748746›Full record

ArticleScientific reports2026

An innovative framework for secure data transmission using machine learning based classification and ElGamal encryption with Ramanujan primes.

N Haritha, Veena Narayanan, R Srikanth

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

N HarithaDepartment of Mathematics, SASTRA Deemed University, Thanjavur, 613401, Tamil Nadu, India.
Veena NarayananDepartment of Mathematics, SASTRA Deemed University, Thanjavur, 613401, Tamil Nadu, India. veenanarayanan@maths.sastra.edu.
R SrikanthDepartment of Mathematics, SASTRA Deemed University, Thanjavur, 613401, Tamil Nadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The secure processing and transmission of sensitive data has arisen as a crucial concern in the modern digital world. This paper presents a conditional ElGamal framework in which the prime modulus is chosen from either conventional primes or the Ramanujan prime based on data sensitivity, while the encryption and decryption techniques remain identical to the standard ElGamal scheme. To classify data into normal and highly sensitive categories, several machine learning models are evaluated among which the Support Vector Machine model achieves highest mean accuracy under 5-fold cross-validation. The normal sensitive data is encrypted using the standard ElGamal encryption method whereas highly sensitive data is encrypted by using the proposed variant with Ramanujan prime-based key generation. The security analysis confirmed that the proposed framework preserves the security of standard ElGamal scheme under known-plain text attack and chosen-plain text attack. The choice of Ramanujan primes affects only the key-generation procedure and does not change or strengthen the theoretical security guarantees of ElGamal scheme. To ensure both data credibility and reliability, a hash-based message authentication code is appended to each message before transmission. The encryption-decryption time and the average data rate for highly sensitive data is less compared to the normal sensitive data which ensures the less CPU memory usage of the new framework. Hence, the proposed framework can be suitable for applications in cloud computing, healthcare, and e-governance environments.

Indexed as

Data classificationElGamal encryptionHMACMachine learning algorithmsRamanujan primes

Identifiers

PMID41748746
PMCPMC13043681

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.